216 related articles for article (PubMed ID: 30031864)
1. Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.
Zaman RU; Mulla NS; Braz Gomes K; D'Souza C; Murnane KS; D'Souza MJ
Int J Pharm; 2018 Sep; 548(1):698-706. PubMed ID: 30031864
[TBL] [Abstract][Full Text] [Related]
2. Lactosylated PLGA nanoparticles containing ϵ-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins.
Zhou P; An T; Zhao C; Li Y; Li R; Yang R; Wang Y; Gao X
Int J Pharm; 2015 Jan; 478(2):633-43. PubMed ID: 25510599
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin.
Oppong-Damoah A; Zaman RU; D'Souza MJ; Murnane KS
Horm Behav; 2019 Feb; 108():20-29. PubMed ID: 30593782
[TBL] [Abstract][Full Text] [Related]
4. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of vinculin-targeted polymer-lipid nanoparticle as intracellular delivery vehicle.
Wang J; Ornek-Ballanco C; Xu J; Yang W; Yu X
Int J Nanomedicine; 2013; 8():39-46. PubMed ID: 23293518
[TBL] [Abstract][Full Text] [Related]
7. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.
Egusquiaguirre SP; Manguán-García C; Pintado-Berninches L; Iarriccio L; Carbajo D; Albericio F; Royo M; Pedraz JL; Hernández RM; Perona R; Igartua M
Eur J Pharm Biopharm; 2015 Apr; 91():91-102. PubMed ID: 25660910
[TBL] [Abstract][Full Text] [Related]
8. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
[TBL] [Abstract][Full Text] [Related]
9. Anhydrous reverse micelle lecithin nanoparticles/PLGA composite microspheres for long-term protein delivery with reduced initial burst.
Chen L; Mei L; Feng D; Huang D; Tong X; Pan X; Zhu C; Wu C
Colloids Surf B Biointerfaces; 2018 Mar; 163():146-154. PubMed ID: 29291500
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-conjugated poly(lactic-co-glycolic acid) nanoparticles for protein delivery to macrophages.
Lee SY; Cho HJ
J Colloid Interface Sci; 2017 Mar; 490():391-400. PubMed ID: 27914338
[TBL] [Abstract][Full Text] [Related]
11. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
[TBL] [Abstract][Full Text] [Related]
12. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
[TBL] [Abstract][Full Text] [Related]
13. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.
Pakulska MM; Elliott Donaghue I; Obermeyer JM; Tuladhar A; McLaughlin CK; Shendruk TN; Shoichet MS
Sci Adv; 2016 May; 2(5):e1600519. PubMed ID: 27386554
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
17. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.
Amoozgar Z; Wang L; Brandstoetter T; Wallis SS; Wilson EM; Goldberg MS
Biomacromolecules; 2014 Nov; 15(11):4187-94. PubMed ID: 25251833
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
Girotra P; Singh SK
Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
